Describe the microbiome and its systemic effects

Overview

The microbiome is the collection of all microorganisms (bacteria, archaea, fungi, viruses, protists) and their genes living in and on the human body. This note explores how these trillions of microbes influence health and disease at the systems level, far beyond local gut effects.

---

Core Concepts

WHY focus on gut? It has the highest density, greatest metabolic activity, and most direct access to systemic circulation via the portal vein to the liver.

---

Establishing the Microbiome: Early Life

$\text{Sterile womb} \rightarrow \text{Birth mode} \rightarrow \text{Feeding} \rightarrow \text{Environment} \rightarrow \text{Stable adult microbiome (age ~3)}$

DERIVATION of why birth mode matters:

1. Vaginal delivery: Baby swallows maternal vaginal microbes (Lactobacillus, Prevotella, Sneathia)
   • WHY these? Vaginal Lactobacillus produce lactic acid → acidic environment → trains infant immune system tolerate commensals
2. C-section delivery: Baby's first colonizers come from skin (Staphylococcus, Corynebacterium)
   • CONSEQUENCE: Different immune training → epidemiological links to higher allergy/asthma rates (though confounders exist)

Breastfeeding impact:

• Human milk contains human milk oligosaccharides (HMOs)—complex sugars the INFANT cannot digest
• WHY have them? They selectively feed Bifidobacterium and Bacteroides species that CAN digest them
• These bacteria produce short-chain fatty acids (SCFAs) like butyrate → fuel for gut cells + anti-inflammatory signals

Step 2: Bifidobacterium longum subsp. infantis in the colon expresses fucosidase enzymes

• Why this step? This strain evolved with human milk; the genes for HMO breakdown are on specific genomic island

Step 3: B. infantis metabolizes HMOs to lactate and acetate

• Why this step? These SCFAs lower colonic pH, inhibiting pathogen growth (Clostridium, Salmonella prefer neutral pH)

Step 4: Acetate absorbed → enters bloodstream → reaches immune organs

• Why this step? Acetate promotes regulatory T cell (Treg) differentiation in the thymus and gut-associated lymphoid tissue (GALT)

RESULT: Breastfed infants have 10× more Bifidobacterium and stronger Treg responses compared to formula-fed infants (who develop more diverse but less specialized microbiomes earlier).

---

Mechanisms of Systemic Effects

1. Metabolite Production and Signaling

$\text{Dietary fiber (resistant starch, inulin)} \xrightarrow{\text{Bacteroides, Faecalibacterium, Roseburia}} \text{Butyrate, Propionate, Acetate}$

DERIVATION of butyrate's systemic effects from first principles:

Step 1: Butyrate crosses the gut epithelium via monocarboxylate transporter 1 (MCT1)

• WHY? Colonocytes (gut lining cells) use butyrate as their PRIMARY fuel source (70% of energy)
• Verification: Colonocyte oxygen consumption drops 70% when butyrate is absent

Step 2: Butyrate enters the bloodstream → reaches liver, brain, immune cells

• WHY systemic? Portal vein → liver gets highest concentration (some metabolized), but ~10-20% reaches systemic circulation

Step 3: Butyrate inhibits histone deacetylases (HDACs) in immune cells

• WHY this mechanism? HDACs normally remove acetyl groups from histone tails → condensed chromatin → genes OFF
• Butyrate blocks HDACs → acetyl groups stay → open chromatin → specific genes turn ON

Step 4: Open chromatin at the FOXP3 locus in naïve T cells

• WHY FOXP3? Master regulator transcription factor for regulatory T cells (Tregs)
• RESULT: More Tregs produced → suppression of inflammatory responses

Mathematical representation of HDAC inhibition: $\text{Gene expression} \propto \frac{[\text{Acetyl-CoA}]}{K_m +[\text{Butyrate}] \cdot K_i}$

Where $K_i$ is the inhibition constant for butyrate binding to HDAC active site. Higher butyrate → stronger inhibition → more acetylation → more transcription of anti-inflammatory genes.

Step 1: Increased colonic Bacteroides → more propionate production

• Why this step? Bacteroides encode succinate pathway for propionate synthesis from succinate via methylmalonyl-CoA

Step 2: Propionate absorbed → travels via portal vein to liver

• Why this step? Liver expresses high levels of GPR43 (FFAR2), a G-protein coupled receptor for SCFAs

Step 3: Propionate binds GPR43 on hepatocytes

• Why this step? GPR43 activation triggers Gαi signaling → inhibits cAMP production

Step 4: Lower cAMP → reduced protein kinase A (PKA) activity → less CREB phosphorylation

• Why this step? CREB normally activates gluconeogenesis genes (PEPCK, G6Pase)

Step 5: Decreased hepatic glucose production

• Why this step? Less gluconeogenesis → lower fasting blood glucose

RESULT: Human trials show 10-15% reduction in fasting glucose after 4 weeks of resistant starch supplementation (which bosts propionate).

2. Immune System Education

$\text{Microbial diversity} \propto \frac{1}{\text{Allergic/Autoimmune risk}}$

DERIVATION of mechanism:

Step 1: Pattern recognition receptors (PRRs) on dendritic cells detect microbial molecules

• WHY PRs? Toll-like receptors (TLRs), NOD-like receptors sense conserved microbial patterns (LPS, flagelin, peptidoglycan)
• KEY POINT: Different microbes trigger different TLR combinations

Step 2: Specific TLR combinations determine dendritic cell maturation state

• Example: TLR2 + TLR4 activation → semi-mature dendritic cells
• WHY semi-mature? They upregulate co-stimulatory molecules BUT produce more IL-10 (anti-inflammatory)

Step 3: Semi-mature DCs migrate to mesenteric lymph nodes

• WHY there? The gut's immune headquarters—where T cells get educated

Step 4: Semi-mature DCs present comensal antigens to naïve T cells in context of IL-10 and TGF-β

• WHY this cytokine combo? IL-10 + TGF-β drive FOXP3 expression → Treg differentiation

Step 5: Tregs specific to commensal microbes exit lymph nodes → circulate systemically

• WHY systemic? These Tregs suppress bystander inflammation everywhere (not just gut)
• MECHANISM: Produce IL-10 and TGF-β that dampen nearby effector T cells

Step 1: Introduce SFB (Candidatus Arthromitus)

• Why this step? SFB attach intimately to ileal epithelial cells (unique among gut bacteria)

Step 2: Epithelial cells upregulate serum amyloid A (SAA) proteins

• Why this step? SFB attachment triggers NF-κB signaling in epithelial cells → SAA secretion

Step 3: SAA activates dendritic cells in Peyer's patches

• Why this step? SA binds TLR2/4 → DCs produce IL-6, IL-23, TGF-β

Step 4: This cytokine trio drives Th17 differentiation (not Treg)

• Why this step? IL-6 + TGF-β → RORγt expression (Th17 master regulator)
• IL-23 stabilizes Th17 phenotype

Step 5: Th17 cells produce IL-17 and IL-22

• Why this step? IL-17 recruits neutrophils, IL-22 induces antimicrobial peptides (RegIIIγ)

RESULT: SFB colonization → 100-fold increase in Th17 cells → enhanced defense against Citrobacter rodentium and Candida albicans. But TRADE-OFF: mice more susceptible to autoimmune arthritis (Th17 cells cross-react with self-antigens).

Clinical relevance: Some humans harbor SFB-like organisms. Higher Th17 → better anti-fungal immunity but higher inflammatory bowel disease risk.

3. Gut-Brain Axis

$\text{Microbe signals} \leftrightarrow \begin{cases} \text{Vagus nerve (neural)} \ \text{Immune cytokines (immunological)} \\ \text{Microbial metabolites (endocrine)} \\ \text{Tryptophan metabolism (neurochemical)} \end{cases} \leftrightarrow \text{Brain}$

DERIVATION of tryptophan pathway effects:

Step 1: Dietary tryptophan reaches colon

• WHY? Not all absorbed in small intestine; ~5% reaches microbes

Step 2: Gut bacteria metabolize tryptophan via three pathways:

1. Indole pathway: Tryptophanase enzyme → indole, indole-3-acetic acid (IAA), indole-3-propionic acid (IPA)
   • Bacteria: Clostridium sporogenes, Bacteroides
2. Kynurenine pathway: Mostly host enzymes (but microbes influence via inflammation)
   • Result: Kynurenic acid (neuroprotective) vs Quinolinic acid (neurotoxic)
3. Serotonin pathway: Host enterochromaffin cells produce serotonin (5-HT)
   • Microbial influence: Spore-forming bacteria promote 5-HT synthesis

Step 3: Indole derivatives activate aryl hydrocarbon receptor (AhR)

• WHY AhR? Transcription factor that senses environmental chemicals
• LOCATION: On immune cells, epithelial cells, AND neurons

Step 4: AhR activation in gut maintains epithelial barrier

• WHY? Upregulates tight junction proteins (claudin, occludin)
• CONSEQUENCE: Less "leaky gut" → fewer inflammatory molecules reach bloodstream → less neuroinflammation

Step 5: IPA crosses blood-brain barrier

• WHY can it cross? Lipophilic structure allows passive diffusion
• BRAIN EFFECTS: Neuroprotective against oxidative stress (shown in mouse models of Alzheimer's)

Step 1: L. rhamnosus colonizes gut, produces GABA

• Why this step? This strain has glutamate decarboxylase (converts glutamate → GABA)

Step 2: GABA in gut lumen does NOT cross blood-brain barrier

• Why this step? GABA is hydrophilic, ionized at physiological pH
• WAIT—then how does it work?

Step 3: Gut GABA activates vagal aferents (nerve endings in gut wall)

• Why this step? Vagal nerve endings express GABA receptors (GABA-A and GABA-B)
• MECHANISM: GABA binding → hyperpolarization of vagal nerve → altered firing pattern

Step 4: Vagus nerve signals to nucleus tractus solitarius (NTS) in brainstem

• Why this step? NTS is the first brain relay station for vagal input

Step 5: NTS projects to amygdala (fear center) and prefrontal cortex

• Why this step? These regions regulate anxiety and stress responses

Step 6: Altered amygdala activity → reduced anxiety-like behavior

• RESULT: Mice spent 2× more time in open arms of elevated plus maze

VERIFICATION: When vagus nerve was surgically cut (vagotomy), the probiotic effect disappeared. Proves the mechanism requires vagal signaling, not direct GABA entry to brain.

---

Dysbiosis and Disease

Obesity and Metabolic Syndrome

$\frac{\text{Firmicutes}}{\text{Bacteroidetes}} \text{ is higher in obese vs lean individuals}$

DERIVATION of mechanistic link (updated understanding):

Step 1: Firmicutes (especially Clostridium clusters) are more efficient at extracting energy from fiber

• WHY? Encode more glycoside hydrolases (fiber-digesting enzymes)
• CONSEQUENCE: More SCFAs produced per gram of fiber

Step 2: In context of high-calorie diet, extra energy harvested is stored as fat

• WHY? Excess acetate and propionate → converted to acetyl-CoA → fatty acid synthesis

Step 3: BUT—this alone doesn't explain obesity (SCFAs also promote satiety)

• UPDATED MECHANISM: The key is endotoxemia

Step 4: High-fat diet → reduced mucus layer → bacteria closer to epithelium

• WHY? Saturated fats reduce goblet cell mucin production (MUC2)

Step 5: Bacterial lipopolysaccharide (LPS) leaks into bloodstream

• WHY LPS? Component of Gram-negative bacterial outer membrane (endotoxin)
• MEASUREMENT: Obese individuals have 2-3× higher plasma LPS

Step 6: LPS binds TLR4 on adipocytes and macrophages

• WHY this matters? TLR4 activation → NF-κB signaling → inflammatory cytokine production (TNF-α, IL-6)

Step 7: Chronic low-grade inflammation impairs insulin signaling

• MECHANISM: TNF-α activates JNK → serine phosphorylation of IRS-1 (insulin receptor substrate) → insulin resistance

$\text{Insulin sensitivity} \propto \frac{1}{[\text{TNF-}\alpha] \cdot [\text{IL-6}]}$

Step 1: A. muciniphila degrades mucin (MUC2) in the gut mucus layer

• Why this step? This bacterium specializes in using mucin as its sole carbon source
• Enzyme: Glycosulfatases and glycosidases cleave mucin oligosaccharides

Step 2: Mucin degradation products stimulate goblet cells to produce MORE mucin

• Why this step? Depletion signals trigger compensatory mucus synthesis
• RESULT: Thicker mucus layer (protective barrier)

Step 3: A. muciniphila outer membrane protein Amuc_100 interacts with TLR2

• Why this step? Unlike LPS (pro-inflammatory), Amuc_1100 is anti-inflammatory
• MECHANISM: TLR2 activation → tolerogenic dendritic cell response → IL-10 production

Step 4: Thicker mucus + anti-inflammatory signals → reduced endotoxemia

• Why this step? Bacteria stay farther from epithelium → less LPS leakage

Step 5: Lower systemic inflammation → improved insulin sensitivity

• RESULT: Mice given A. muciniphila show 50% improvement in glucose tolerance

Human trial: Pasteurized A. muciniphila (daily for 3 months) reduced insulin resistance in overweight humans by 30% (Depommier et al., 2019). Pasteurization was needed because live bacteria didn't survive stomach acid in sufficient numbers.

Inflammatory Bowel Disease (IBD)

$\text{Stability} = \sum_{i=1}^{n} (\text{Functional group}_i) \times (\text{Species diversity within group}_i)$

In IBD, specific functional losses occur:

Step 1: Reduced butyrate-producing bacteria (Faecalibacterium prausnitzii, Roseburia)

• WHY? These are oxygen-sensitive anaerobes; inflammation → oxygen leak into lumen → die-off
• CONSEQUENCE: 70% less butyrate → colonocytes starve → barrier weakens

Step 2: Barrier weakening → more bacterial antigens cross epithelium

• WHY this matters? Adaptive immune system sees antigens → mounts response

Step 3: In genetically susceptible individuals (NOD2 mutations, etc.), response is exaggerated

• WHY NOD2? Normally senses bacterial peptidoglycan → measured response
• MUTATION effect: Either overeaction or failure to sense → dysregulated inflammation

Step 4: Inflammatory cytokines (TNF-α, IL-12, IL-23) → Th1 and Th17 expansion

• WHY these cells? Produce IFN-γ and IL-17 → recruit more neutrophils → tissue damage

Step 5: Tissue damage → more oxygen → more butyrate-producer die-off

• RESULT: Vicious cycle—inflammation → dysbiosis → more inflammation

Why it feels right: Some IBD patients have adherent-invasive E. coli (AIEC), and antibiotics sometimes help acutely.

What's actually happening:

1. AIEC is an opportunist, not the root cause—it thrives in the inflamed, low-butyrate environment
2. The problem is loss of protective bacteria (F. prausnitzii), not just presence of AIEC
3. Antibiotics may reduce bacterial load temporarily, but don't restore protective functions
4. Evidence: Fecal microbiota transplant (FMT) from healthy donors to IBD patients shows modest benefit (40% response in ulcerative colitis), proving restoration matters more than elimination

The fix: Focus on restoring butyrate production (prebiotics like inulin, or engineering bacteria to overproduce butyrate) and anti-inflammatory taxa like A. muciniphila. Combination therapies targeting inflammation + dysbiosis work better than either alone.

---

Manipulating the Microbiome

Probiotics

Why probiotics often fail:

1. Colonization resistance: Resident microbes occupy niches, produce bacteriocins
2. Lack of persistence: Most probiotic strains don't permanently colonize (cleared within 2 weeks of stopping)
3. Context-dependent: Same strain helps in antibiotic-associated diarrhea but not in Crohn's disease

When they work:

• Lactobacillus reuteri: Reduces infantile colic (produces reuterin, antimicrobial that inhibits gas-producing bacteria)
• Sacharomyces boulardii: Prevents C. difficile recurrence (produces proteases that degrade C. difficile toxins A and B)
• VSL#3 (8-strain mixture): Maintains remission in ulcerative colitis (synergistic SCFA production)

Prebiotics

MECHANISM:

1. Prebiotics reach colon undigested (resistant to human enzymes)
2. Specific bacteria (Bifidobacterium, Faecalibacterium) have enzymes to break them down
3. Growth advantage → these populations expand
4. Increased SCFA production → systemic benefits

Advantage over probiotics: Feeds YOUR existing beneficial strains (personalized), rather than introducing foreign strains that may not colonize.

Fecal Microbiota Transplantation (FMT)

DERIVATION of why FMT works in C. diff but not consistently elsewhere:

Step 1: Recurrent C. difficile infection (rCDI) is caused by loss of colonization resistance after antibiotics

• WHY? Antibiotics kill diverse microbiota → empty niches → C. diff spores germinate and dominate

Step 2: Healthy donor stool contains diverse bacteria that produce:

• Secondary bile acids (deoxycholate, lithocholate) that inhibit C. diff germination
• Bacteriocins and competing for nutrients

Step 3: FMT rapidly restores diversity (within 24-48 hours in colon)

• WHY so fast? Most bacteria are already adapted to gut environment, just need to establish

Step 4: Secondary bile acid levels rise10-fold within 1week

• MECHANISM: Donor bacteria encode7α-dehydroxylase → converts primary to secondary bile acids
• RESULT: C. diff spores cannot germinate → infection clears

In IBD: The problem is NOT just missing microbes, but ongoing inflammation and genetic susceptibility. FMT introduces healthy microbes, but if the inflammatory environment persists, they can't thrive. Hence lower success rate.

---

Testing and Personalization

$H' = -\sum_{i=1}^{S} p_i \ln p_i$

Where:

• $S$ = total number of species
• $p_i$ = proportion of species $i$

WHY this metric? Captures both how many species (richness) and how evenly distributed (evenness). A microbiome with 100 species but 90% dominated by one has LOWER diversity than 50 species evenly distributed.

Clinical relevance: Alpha diversity <3.0 associated with higher risk of C. difficile infection, metabolic syndrome, and IBD.

Finding: Identical meals caused vastly different glucose spikes between individuals (same person, same meal = consistent; different people, same meal = variable).

Microbiome link:

• High Prevotella copri → large glucose spike from complex carbs (Prevotella degrades fiber rapidly → fast glucose release)
• High Bacteroides → smaller, sustained glucose rise (Bacteroides produces more propionate → hepatic glucose regulation)

Step 1: Sequence participant's gut microbiome (16S rRNA or shotgun metagenomic sequencing)

Step 2: Machine learning model trained on microbiome + meal composition + glucose response

• Features: 137 microbiome features (species abundances, functional genes) + meal macros

Step 3: Model predicts personalized glucose response to new meals

• Accuracy: r = 0.68 (much better than glycemic index predictions)

Step 4: Personalized diet recommendations based on predicted responses

• Result: Following personalized diet reduced glucose spikes by 30% more than standard diet

IMPLICATION: "Eat more fiber" is too general—the TYPE of fiber and your existing microbiome determine the benefit.

---

Summary of Systemic Effects

System	Microbial Mechanism	Clinical Consequence
Immune	SCFA-driven Treg induction; LPS-driven inflammation	Allergy, autoimmunity, IBD
Metabolic	Energy harvest; LPS endotoxemia; bile acid modification	Obesity, diabetes, NAFLD
Neurological	Vagal signaling; tryptophan metabolites; neurotransmitter production	Anxiety, depression, autism spectrum (associations)
Cardiovascular	TMAO production from choline/carnitine; SCFA effects on blood pressure	Atherosclerosis risk
Hepatic	Portal vein delivery of metabolites; secondary bile acids	Liver inflammation, cirhosis

---

Recall Explain It to a 12-Year-Old

Imagine your gut is like a huge city inside you, with trillions of tiny living creatures (bacteria and other microbes) as the citizens. These aren't germs making you sick—they're helpers! They do jobs your body can't do alone, like making vitamins and teaching your immune system who's a friend and who's an enemy.

Here's the wild part: these gut microbes talk to the REST of your body, even your brain! They make special chemicals called short-chain fatty acids (like butyrate) when they eat fiber from your food. These chemicals travel in your blood to your brain, fat cells, and your immune cells, telling them how to behave. Some gut bacteria even make the same "happy chemicals" as your brain (like serotonin).

When the microbe city is balanced and diverse (lots of different species), you're healthier—better mood, stronger immune system, less inflammation. But when the balance is thrown off (like after taking antibiotics, or eating only junk food), bad things can happen: you might gain weight easier, get more allergies, or even feel more anxious.

Scientists can now look at your specific microbe city and figure out what YOU need to keep it healthy—because everyone's microbiome is unique, like a fingerprint!

---

Connections

• Innate Immunity – PRs detect microbial patterns, trained by microbiome
• Adaptive Immunity – Treg education by comensal antigens
• Digestive System Anatomy – Physical structure of gut-associated lymphoid tissue (GALT)
• Metabolic Pathways – SCFA metabolism and gluconeogenesis regulation
• Neurotransmitters – Serotonin, GABA, dopamine production by microbes
• Epigenetics – HDAC inhibition by butyrate changes gene expression
• Evolution and Coevolution – Host-microbe coevolution over millions of years
• Antibiotic Resistance – Collateral damage of antibiotics on microbiome diversity

---

#flashcards/biology

What is the difference between microbiota and microbiome? :: Microbiota = the living microrganisms themselves; Microbiome = microrganisms PLUS their genes, metabolites, and environment. We care about function (what microbes DO), not just identity.

Concept Map

Hinglish (regional understanding)

Intuition Hinglish mein samjho

Hinglish (regional understanding)

Intuition Hinglish mein samjho

Dekho, socho ki tumhara body ek badi city hai jisme trillions of tiny microbes—bacteria, fungi, viruses—rehte hain, aur inn sabko milakar hum microbiome kehte hain. Yeh microbes sirf free me nahi reh rahe—yeh tumhare liye kaam karte hain: vitamins banate hain jo tum khud nahi bana sakte, tumhare immune system ko sikhate hain ki friend kaun hai aur enemy kaun, aur mood-affecting neurotransmitters tak produce karte hain. Jab yeh microbes balanced hote hain use hum eubiosis kehte hain, aur jab imbalance ho jaaye to dysbiosis—jiski wajah se inflammation, metabolic disease, aur behavior tak change ho sakta hai. Yaad rakhna important distinction: microbiota matlab actual living cells, aur microbiome matlab woh cells PLUS unke genes aur metabolites—kyunki asli baat yeh hai ki microbes KYA karte hain, sirf kaun present hai woh nahi.

Ab yeh systemic kyun matter karta hai? Kyunki microbial metabolites tumhare bloodstream me chale jaate hain, unke molecules immune cells ko train karte hain jo poore body me travel karti hain, aur gut-brain, gut-liver, gut-lung axis ke through distant organs tak signal pahunchte hain. Sabse important gut microbiome hota hai—kyunki iski density sabse zyada hai, metabolic activity sabse high, aur portal vein ke through liver aur systemic circulation tak direct access milta hai. Isiliye gut ki health bas pet tak seemit nahi—yeh poore body ko affect karti hai.

Ek interesting cheez hai early life ka critical window—pehle 3 saal jab microbiome establish hota hai. Birth mode bhi matter karta hai: vaginal delivery me baby maa ke Lactobacillus jaise microbes swallow karta hai jo immune system ko sahi tarah train karte hain, jabki C-section me skin ke microbes pehle aate hain. Breastfeeding me HMOs (human milk oligosaccharides) hote hain—aise complex sugars jo baby khud digest nahi kar sakta, lekin yeh specifically Bifidobacterium jaise good bacteria ko feed karte hain. Yeh bacteria phir SCFAs jaise butyrate aur acetate banate hain jo gut cells ko fuel dete hain, pH lower karke pathogens ko rokte hain, aur Treg cells ko promote karke immune system ko calm rakhte hain. Simple language me—maa ka doodh soch-samajh ke sahi bacteria ko khilaata hai, aur woh bacteria baby ko protect karte hain.